|
|||||
|
|
Adding carboplatin to chemotherapy regimens for metastatic castrate-resistant prostate cancer in postsecond generation hormone therapy setting: Impact on treatment response and survival outcomes |
|
| Authors: | Mohamed E. Ahmed MB BCh Jack R. Andrews MD Jamal Alamiri MB BCh Julianna Higa BSc Rimki Haloi MBBS Manaf Alom MBBS Giovanni Motterle MD Vidhu Joshi BSc Paras H. Shah MD R. Jeffrey Karnes MD Eugene Kwon MD |
| Affiliation: | Department of Urology, Mayo Clinic, Rochester, Minnesota |
| Abstract: | |
| Keywords: | advanced prostate cancer cabazitaxel docetaxel hormone refractory prostate cancer second-generation hormone therapy |